Neurocrine Biosciences Stock Options
| NBIX Stock | USD 153.29 2.61 1.73% |
Neurocrine Biosciences' latest option contracts expiring on March 21st 2025 are carrying combined implied volatility of 0.59 with a put-to-call open interest ratio of 1.46 over 50 outstanding agreements suggesting investors are buying way more puts than calls on contracts expiring on March 21st 2025.
Open Interest Against March 21st 2025 Option Contracts
Neurocrine Biosciences option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Neurocrine Biosciences' lending market. For example, when Neurocrine Biosciences' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Neurocrine Biosciences, he or she must hedge the risk by shorting Neurocrine Biosciences stock over its option's life.
2025-03-21
The chart above shows Neurocrine Biosciences' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Neurocrine Biosciences' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Neurocrine Biosciences' option, there is no secondary market available for investors to trade.
In The Money vs. Out of Money Option Contracts on Neurocrine Biosciences
Analyzing Neurocrine Biosciences' in-the-money options over time can help investors to take a profitable long position in Neurocrine Biosciences regardless of its overall volatility. This is especially true when Neurocrine Biosciences' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Neurocrine Biosciences' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Neurocrine Biosciences' stock while costing only a fraction of its price.
Neurocrine Biosciences In The Money Call Balance
When Neurocrine Biosciences' strike price is surpassing the current stock price, the option contract against Neurocrine Biosciences stock is said to be in the money. When it comes to buying Neurocrine Biosciences' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Neurocrine Biosciences are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Neurocrine Current Options Market Mood
Neurocrine Biosciences' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Neurocrine Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Neurocrine Biosciences' options investors are not very successful. Neurocrine Biosciences' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Neurocrine contract
Base on the Rule 16, the options market is currently suggesting that Neurocrine Biosciences will have an average daily up or down price movement of about 0.0369% per day over the life of the 2025-03-21 option contract. With Neurocrine Biosciences trading at USD 153.29, that is roughly USD 0.0565. If you think that the market is fully incorporating Neurocrine Biosciences' daily price movement you should consider buying Neurocrine Biosciences options at the current volatility level of 0.59%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Neurocrine |
Purchasing Neurocrine Biosciences options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Neurocrine calls. Remember, the seller must deliver Neurocrine Biosciences stock to the call owner when a call is exercised.
Neurocrine Biosciences Option Chain
When Neurocrine Biosciences' strike price is surpassing the current stock price, the option contract against Neurocrine Biosciences stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Neurocrine Biosciences' option chain is a display of a range of information that helps investors for ways to trade options on Neurocrine. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Neurocrine. It also shows strike prices and maturity days for a Neurocrine Biosciences against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | NBIX250321C00095000 | 11 | 95.0 | 56.5 - 61.4 | 31.8 | In |
Call | NBIX250321C00100000 | 11 | 100.0 | 52.0 - 56.5 | 47.0 | In |
Call | NBIX250321C00105000 | 5 | 105.0 | 46.9 - 51.5 | 14.0 | In |
Call | NBIX250321C00110000 | 8 | 110.0 | 42.2 - 46.5 | 21.07 | In |
Call | NBIX250321C00115000 | 33 | 115.0 | 36.5 - 41.4 | 26.5 | In |
Call | NBIX250321C00120000 | 48 | 120.0 | 32.1 - 36.5 | 19.59 | In |
Call | NBIX250321C00125000 | 25 | 125.0 | 27.1 - 31.5 | 22.0 | In |
Call | NBIX250321C00130000 | 59 | 130.0 | 22.5 - 27.0 | 16.6 | In |
Call | NBIX250321C00135000 | 25 | 135.0 | 19.7 - 22.5 | 20.39 | In |
Call | NBIX250321C00140000 | 61 | 140.0 | 15.6 - 18.5 | 12.0 | In |
Call | NBIX250321C00145000 | 276 | 145.0 | 10.3 - 14.5 | 11.7 | In |
Call | NBIX250321C00150000 | 27 | 150.0 | 6.9 - 11.5 | 8.3 | In |
Call | NBIX250321C00155000 | 7 | 155.0 | 4.6 - 9.0 | 4.4 | Out |
Call | NBIX250321C00160000 | 41 | 160.0 | 3.6 - 4.9 | 4.3 | Out |
Call | NBIX250321C00165000 | 31 | 165.0 | 0.55 - 3.3 | 2.5 | Out |
Call | NBIX250321C00170000 | 23 | 170.0 | 0.1 - 2.45 | 2.24 | Out |
Call | NBIX250321C00175000 | 3 | 175.0 | 0.0 - 4.8 | 1.58 | Out |
Call | NBIX250321C00180000 | 3 | 180.0 | 0.0 - 4.8 | 1.86 | Out |
Call | NBIX250321C00185000 | 0 | 185.0 | 0.0 - 4.8 | 4.8 | |
Call | NBIX250321C00190000 | 1 | 190.0 | 0.0 - 4.8 | 10.1 | Out |
Call | NBIX250321C00195000 | 0 | 195.0 | 0.0 - 4.8 | 4.8 | |
Call | NBIX250321C00200000 | 1 | 200.0 | 0.05 - 4.9 | 8.2 | Out |
Call | NBIX250321C00210000 | 0 | 210.0 | 0.0 - 4.8 | 8.0 | |
Call | NBIX250321C00220000 | 2 | 220.0 | 0.0 - 4.8 | 4.29 | Out |
Call | NBIX250321C00230000 | 0 | 230.0 | 0.0 - 4.8 | 4.8 | |
Put | NBIX250321P00070000 | 11 | 70.0 | 0.0 - 4.8 | 0.8 | Out |
Put | NBIX250321P00075000 | 1 | 75.0 | 0.0 - 4.8 | 0.5 | Out |
Put | NBIX250321P00080000 | 10 | 80.0 | 0.0 - 4.8 | 1.15 | Out |
Put | NBIX250321P00085000 | 26 | 85.0 | 0.0 - 4.8 | 1.45 | Out |
Put | NBIX250321P00090000 | 7 | 90.0 | 0.0 - 4.8 | 1.8 | Out |
Put | NBIX250321P00095000 | 9 | 95.0 | 0.0 - 4.8 | 1.7 | Out |
Put | NBIX250321P00100000 | 3 | 100.0 | 0.0 - 4.8 | 2.5 | Out |
Put | NBIX250321P00105000 | 12 | 105.0 | 0.0 - 4.8 | 1.25 | Out |
Put | NBIX250321P00110000 | 201 | 110.0 | 0.0 - 4.8 | 1.7 | Out |
Put | NBIX250321P00115000 | 59 | 115.0 | 0.0 - 4.8 | 1.5 | Out |
Put | NBIX250321P00120000 | 593 | 120.0 | 0.0 - 4.8 | 2.6 | Out |
Put | NBIX250321P00125000 | 83 | 125.0 | 0.0 - 4.7 | 7.1 | Out |
Put | NBIX250321P00130000 | 5 | 130.0 | 0.0 - 4.8 | 3.2 | Out |
Put | NBIX250321P00135000 | 2 | 135.0 | 0.0 - 4.8 | 2.16 | Out |
Put | NBIX250321P00140000 | 1 | 140.0 | 0.0 - 4.7 | 2.77 | Out |
Put | NBIX250321P00170000 | 0 | 170.0 | 15.5 - 20.3 | 15.5 | In |
Put | NBIX250321P00175000 | 0 | 175.0 | 20.2 - 24.8 | 20.2 | In |
Put | NBIX250321P00180000 | 0 | 180.0 | 24.5 - 29.3 | 24.5 | In |
Put | NBIX250321P00185000 | 0 | 185.0 | 29.5 - 34.4 | 29.5 | In |
Put | NBIX250321P00190000 | 0 | 190.0 | 34.5 - 39.0 | 34.5 | In |
Put | NBIX250321P00195000 | 0 | 195.0 | 39.2 - 44.0 | 39.2 | In |
Put | NBIX250321P00200000 | 0 | 200.0 | 44.5 - 49.0 | 44.5 | In |
Put | NBIX250321P00210000 | 0 | 210.0 | 54.5 - 59.0 | 54.5 | In |
Put | NBIX250321P00220000 | 0 | 220.0 | 64.5 - 69.0 | 64.5 | In |
Put | NBIX250321P00230000 | 0 | 230.0 | 74.5 - 79.0 | 74.5 | In |
Neurocrine Biosciences Market Cap Over Time
Market Cap |
| Timeline |
Neurocrine Total Stockholder Equity
Total Stockholder Equity |
|
Neurocrine Biosciences Corporate Management
| Julie Cooke | Chief People Officer | Profile | |
| Matthew Abernethy | Chief Officer | Profile | |
| Eric Benevich | Chief Commercial Officer | Profile | |
| Darin Lippoldt | Chief Legal Officer | Profile | |
| Jude Onyia | Chief Officer | Profile | |
| Dimitri Grigoriadis | Chief Research Officer | Profile | |
| Kyle Gano | Chief Business Development Officer | Profile |
Additional Tools for Neurocrine Stock Analysis
When running Neurocrine Biosciences' price analysis, check to measure Neurocrine Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neurocrine Biosciences is operating at the current time. Most of Neurocrine Biosciences' value examination focuses on studying past and present price action to predict the probability of Neurocrine Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neurocrine Biosciences' price. Additionally, you may evaluate how the addition of Neurocrine Biosciences to your portfolios can decrease your overall portfolio volatility.